Harmony Biosciences Holdings Inc. (HRMY) News
Filter HRMY News Items
HRMY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HRMY News Highlights
- For HRMY, its 30 day story count is now at 4.
- Over the past 10 days, the trend for HRMY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about HRMY are BLI, DRUG and RARE.
Latest HRMY News From Around the Web
Below are the latest news stories about Harmony Biosciences Holdings Inc that investors may wish to consider to help them evaluate HRMY as an investment opportunity.
Berkeley Lights, Inc. (BLI) Reports Q4 Loss, Tops Revenue EstimatesBerkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -4% and 5.03%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
3 Desirable Drug Stocks With Very Promising PipelinesDrug makers with superb pipelines are likely to deliver great returns for long-term investors. |
Read This Before Judging Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) ROEOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will... |
Harmony Biosciences Announces Date of Fourth Quarter and Full Year 2021 Financial ResultsHarmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Company's fourth quarter and full year 2021 financial results on Monday, February 28, 2022. Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET. |
When To Sell A Stock: This IBD 50 Pharma Stock Plummeted — Here's How To Avoid Major LossesOn Jan. 5, Harmony shares triggered an important sell rule upon entering the 7%-8% sell zone. |
Harmony Biosciences to Participate in 40th Annual J.P. Morgan Healthcare ConferenceHarmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs will present a company update and host investor meetings at the upcoming 40th Annual J.P. Morgan Healthcare Conference. |
Datadog, Applied Materials Lead Five Stocks Near Buy Points For The New YearYour stocks to watch for the week ahead are Datadog, Endava, Harmony Biosciences, Applied Materials and Danaher. AMAT stock and Danaher are on SwingTrader. Shares of Datadog are in a consolidation with a 186.38 handle buy point. |
Analysts Expect Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Will Post Earnings of $0.34 Per ShareEquities research analysts expect Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) to announce earnings per share of $0.34 for the current quarter, Zacks reports. Four analysts have made estimates for Harmony Biosciences’ earnings, with the highest EPS estimate coming in at $0.42 and the lowest estimate coming in at $0.27. Harmony Biosciences reported earnings per share of […] |
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest UpdateHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 3,220,000 shares, an increase of 22.0% from the November 15th total of 2,640,000 shares. Currently, 12.9% of the companys stock are short sold. Based on an average daily volume [] |
Harmony Biosciences to be Added to the Nasdaq Biotech IndexHarmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI). Harmony's addition to the NBI will become effective prior to market open on Monday, December 20, 2021. |